Yatin Suneja
Stock Analyst at Guggenheim
(2.25)
# 2,602
Out of 4,711 analysts
107
Total ratings
44.57%
Success rate
-4.88%
Average return
Main Sectors:
Stocks Rated by Yatin Suneja
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANAB AnaptysBio | Maintains: Buy | $90 → $36 | $14.55 | +147.42% | 11 | Dec 12, 2024 | |
| QTTB Q32 Bio | Downgrades: Neutral | n/a | $3.59 | - | 2 | Dec 12, 2024 | |
| TRML Tourmaline Bio | Reiterates: Buy | n/a | $20.65 | - | 2 | Dec 11, 2024 | |
| ZBIO Zenas BioPharma | Reiterates: Buy | n/a | $10.01 | - | 2 | Dec 3, 2024 | |
| ARGX argenx SE | Maintains: Buy | $585 → $665 | $623.82 | +6.60% | 8 | Nov 1, 2024 | |
| SYRE Spyre Therapeutics | Maintains: Buy | $50 → $65 | $23.86 | +172.42% | 1 | Oct 25, 2024 | |
| VIGL Vigil Neuroscience | Maintains: Buy | $17 → $16 | $1.70 | +841.18% | 2 | Aug 14, 2024 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $155 → $170 | $76.52 | +122.16% | 2 | Aug 14, 2024 | |
| NBIX Neurocrine Biosciences | Maintains: Buy | $170 → $180 | $135.42 | +32.92% | 3 | Aug 2, 2024 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $1,180 → $1,300 | $701.85 | +85.22% | 5 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $8.82 | +262.81% | 1 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.83 | - | 3 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $7.65 | +553.59% | 1 | Apr 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $90 | $25.14 | +258.00% | 5 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $125 | $90.73 | +37.77% | 8 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $16 | $11.57 | +38.29% | 2 | Nov 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $77 | $52.17 | +47.59% | 3 | Nov 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $10.85 | +102.76% | 1 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $25.86 | +23.74% | 5 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $34 | $2.38 | +1,328.57% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.34 | - | 3 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $2.28 | +777.19% | 1 | Jun 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $49 | $38.63 | +26.84% | 2 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $55 | $7.10 | +674.65% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $14 | $4.01 | +249.13% | 3 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $270 → $350 | $146.47 | +138.96% | 3 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $2.24 | - | 4 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $22 | $16.87 | +30.41% | 5 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.61 | - | 5 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $10.57 | - | 2 | Nov 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $30 | $7.45 | +302.68% | 2 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.36 | - | 3 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $18.00 | +33.33% | 1 | May 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $34 | $42.02 | -19.09% | 2 | Jan 14, 2020 |
AnaptysBio
Dec 12, 2024
Maintains: Buy
Price Target: $90 → $36
Current: $14.55
Upside: +147.42%
Q32 Bio
Dec 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.59
Upside: -
Tourmaline Bio
Dec 11, 2024
Reiterates: Buy
Price Target: n/a
Current: $20.65
Upside: -
Zenas BioPharma
Dec 3, 2024
Reiterates: Buy
Price Target: n/a
Current: $10.01
Upside: -
argenx SE
Nov 1, 2024
Maintains: Buy
Price Target: $585 → $665
Current: $623.82
Upside: +6.60%
Spyre Therapeutics
Oct 25, 2024
Maintains: Buy
Price Target: $50 → $65
Current: $23.86
Upside: +172.42%
Vigil Neuroscience
Aug 14, 2024
Maintains: Buy
Price Target: $17 → $16
Current: $1.70
Upside: +841.18%
Praxis Precision Medicines
Aug 14, 2024
Maintains: Buy
Price Target: $155 → $170
Current: $76.52
Upside: +122.16%
Neurocrine Biosciences
Aug 2, 2024
Maintains: Buy
Price Target: $170 → $180
Current: $135.42
Upside: +32.92%
Regeneron Pharmaceuticals
Aug 2, 2024
Maintains: Buy
Price Target: $1,180 → $1,300
Current: $701.85
Upside: +85.22%
Jul 23, 2024
Initiates: Buy
Price Target: $32
Current: $8.82
Upside: +262.81%
May 10, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.83
Upside: -
Apr 29, 2024
Initiates: Buy
Price Target: $50
Current: $7.65
Upside: +553.59%
Feb 27, 2024
Maintains: Buy
Price Target: $72 → $90
Current: $25.14
Upside: +258.00%
Feb 21, 2024
Maintains: Buy
Price Target: $110 → $125
Current: $90.73
Upside: +37.77%
Nov 15, 2023
Maintains: Buy
Price Target: $17 → $16
Current: $11.57
Upside: +38.29%
Nov 15, 2023
Maintains: Buy
Price Target: $70 → $77
Current: $52.17
Upside: +47.59%
Oct 10, 2023
Initiates: Buy
Price Target: $22
Current: $10.85
Upside: +102.76%
Sep 22, 2023
Reiterates: Buy
Price Target: $32
Current: $25.86
Upside: +23.74%
Aug 14, 2023
Reiterates: Buy
Price Target: $34
Current: $2.38
Upside: +1,328.57%
Jul 17, 2023
Downgrades: Neutral
Price Target: n/a
Current: $0.34
Upside: -
Jun 22, 2023
Initiates: Buy
Price Target: $20
Current: $2.28
Upside: +777.19%
Jun 15, 2023
Reiterates: Buy
Price Target: $49
Current: $38.63
Upside: +26.84%
May 18, 2023
Maintains: Buy
Price Target: $52 → $55
Current: $7.10
Upside: +674.65%
May 17, 2023
Maintains: Buy
Price Target: $12 → $14
Current: $4.01
Upside: +249.13%
May 1, 2023
Upgrades: Buy
Price Target: $270 → $350
Current: $146.47
Upside: +138.96%
Apr 6, 2023
Upgrades: Buy
Price Target: n/a
Current: $2.24
Upside: -
Jan 3, 2023
Upgrades: Buy
Price Target: $22
Current: $16.87
Upside: +30.41%
Jan 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $5.61
Upside: -
Nov 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $10.57
Upside: -
Nov 11, 2022
Maintains: Buy
Price Target: $42 → $30
Current: $7.45
Upside: +302.68%
Oct 14, 2022
Downgrades: Neutral
Price Target: n/a
Current: $0.36
Upside: -
May 31, 2022
Initiates: Buy
Price Target: $24
Current: $18.00
Upside: +33.33%
Jan 14, 2020
Maintains: Buy
Price Target: $29 → $34
Current: $42.02
Upside: -19.09%